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ABSTRACTShowever, previous studies have shown reduced incidence with extended
prophylaxis. One can infer that improving patient understanding and,
thus, compliance will reduce the incidence of postoperative VTE.
0282: RE-RESECTION TURBT RATE IN PATIENTS WITH HIGH GRADE
BLADDER CANCERS
Michelle Christodoulidou, Jeremy Oates, Karuppana Mohan Pillai. Royal
Blackburn Hospital, Blackburn, East Lanchashire Hospitals Trust, UK.
Aim: Transurethral Re-resection of Bladder Tumour base is often necessary
in high grade tumours to ensure correct staging, especially when no
muscle is present in the initial histological sample. We reviewed the
number of new TURBT performed in the Trust over 12 months and the re-
resection rate for lack of muscle or poor quality specimen.
Method: Retrospective Collection of data was performed from patients
with new bladder cancer diagnosis from 1/9/11 until 31/8/12. All cases that
required re-resection were isolated as a group.
Results: 143 new TURBT were performed in our Trust and in total 25 re-
resections. Most common disease re-resected was G3PT1 and G3PTa with
or without CIS. 21 re-resections (14.7%) were performed due to lack of
muscle or poor quality specimen. Upstaging of disease was present in 16%
(4 cases) in this group. 76% of the cases that needed re-resection, the initial
resections were performed by Trainees.
Conclusions: Early re-resection is signiﬁcantly important in patients with
high grade tumours where correct staging cannot be ensured. Although
our re-resection rate is lower than that in existing literature (22%)
we must ensure that deep muscle is provided in the ﬁrst resected
specimen.
0289: CLINICAL AND FINANCIAL BENEFITS OF RESTRICTED AGAINST
LIBERAL FLUID ADMINISTRATION DURING RADICAL PROSTATECTOMY
Sarvpreet ubee, Matthew Rooney, Mahamad Al-Hahme,
Ramasamy Jaganathan, Pitabas Mishra. The Heart of England NHS Trust,
Birmingham, UK.
Aim: To assess the clinical and ﬁnancial beneﬁts of "Liberal or standard"
(LFA) to "Restricted" (RFA) ﬂuid administration during open radical pros-
tatectomy (ORP)
Materials and Methods: Retrospectively 108 patients who underwent
ORP were identiﬁed. Twenty-three patients were eligible for clinical data
collection in each group. Case note review was done and two groups were
compared with a paired t- test. Potential savings were calculated based on
the collected data by comparing the RFA against LFA. Fluid restriction
protocol was agreed for the RFA group.
Results: In LFA group the mean age was 64.6, weight 79.1kg, ASA1 - 10,
ASA2 - 11 and 21pts had epidural, while for RFA group 64yrs, 81.3kg, ASA1
- 11, ASA2 - 9 and epidural in 18pts. The intraoperative blood loss(p<0.05),
hemoglobin drop(p<0.05) and number of blood transfusions(p<0.05) was
less in the RFA group and statistically signiﬁcant alongwith change in
H+concentration and base excess (p<0.05). The total cost saving with RFA
is £14340 (£623/case) accounting form reduced blood transfusion, crys-
talloid and colloid use and reduces hospital stay.
Conclusion: Restriction of ﬂuid in perioperative period was found to be
superior to the standard ﬂuid management in this cohort of patient un-
dergoing Radical Prostatectomies and was ﬁnancially favourable.
0337: PREDICTING IMMEDIATE LEVEL OF CARE REQUIREMENT
FOLLOWING RADICAL CYSTECTOMY e AUDIT OF OUTCOME
Chrysoula Fragkopoulou, Gavish Munbauhal, Stephen Webber,
Sheila M. Reynolds, Ruth Groves, Patrick E. Cutinha, James W.F. Catto,
Mark D. Haynes, David R. Yates, Jo Buck, Derek J. Rosario. Shefﬁeld
Teaching Hospitals, Shefﬁeld, UK.
Introduction: It is standard practice for patients undergoing radical cys-
tectomy (RC) to be pre- booked for a critical care unit (CCU) bed. This study
aimed to examine early outcomes of RC with regards to requirement for
CCU-speciﬁc intervention.
Methods and Patients: 160 consecutive patients undergoing RC be-
tween November 2010 and May 2012 were reviewed. Associations be-
tween pre- and peri-operative parameters and requirement for CCU
interventions were examined. Patients were classiﬁed as Group A if CCU
stay was  24 hours AND required no intervention or Group B if CCUstay was >24 hours and/or required vasopressor, respiratory or renal
support.
Results: Complete data were available on 124 patients to-date. Median
inpatient stay was 13 days. 30 day mortality was 1.3%. Median CCU stay
was 21.7 hours. 69 patients were in Group A and 55 in Group B. In logistic
regression, age, gender, BMI, ASA grade, Lee Cardiac Risk Index, tumour
stage, urinary diversion, intra-operative vasopressor, intra-operative
transfusion, duration of anaesthesia and blood loss did not predict
outcome.
Conclusions: The majority of RC patients do not require CCU- speciﬁc
intervention. Pre-operative features are unable to identify patients at risk.
Prospective evaluation of more procedure-speciﬁc risk scores as predictors
is required.
0391: TREATMENT OF POST PROSTATECTOMY MALE URINARY INCONTI-
NENCE WITH THE ADVANCE MALE SLING: AN EARLY EXPERIENCE
Gemma McKenzie, Felicity Reeves, Sheilagh Reid. Royal Hallamshire
Hospital, Shefﬁeld, UK.
Introduction: The AdVance male sling has been shown to have
durable outcomes at 3 years for the treatment of post prostatectomy
incontinence.
We represent our single centre experience of the AdVancemale sling and
compare the clinical outcomes with those of the larger case series.
Method: Incontinence was assessed on the basis of pad usage. Sub-
jective results were evaluated using two validated condition speciﬁc
QoL tools, the ICIQ-LUTSqol and ICQ-UI Short Form (Copyright  ICIQ
Group), completed by men before and six weeks following surgery.
Objective results were evaluated using the patients reported pad
usage.
Results: Objective improvement was demonstrated in 80% (4/5) of men.
Complete cure (no pad usage) was demonstrated in 20% (1/5), with a
further 60% (3/5) being signiﬁcantly improved (1-2 pads per day). 20% (1/
5) showed no improvement. The ICIQ-LUTS QoL score showed a signiﬁcant
decrease from a pre-sling median value of 143 (IQR: 129-165) to a post-
sling median value of 61 (IQR: 45-74), highlighting the dramatic QoL
improvement in this group of patients.
Conclusion: The AdVance male sling represents a safe and effective
minimally invasive surgical treatment option for post prostatectomy uri-
nary incontinence, and is accompanied by signiﬁcantly improved QoL.
0428: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY: A RETROSPEC-
TIVE STUDY OF ELECTIVE TREATMENT FOR URETERIC STONES
Sheena Patel, Ali Panah, Junaid Masood. Barts and the London, London, UK.
Introduction: Extracorporeal shockwave lithotripsy (ESWL) is a non-
invasive method of stone fragmentation. Although less successful at lower
frequencies, higher frequencies can cause tissue damage. There is no
guidance on shockwave administration or frequency of sessions. This
study assesses efﬁciency of elective ESWL in ureteric stones.
Methods: A 15-month retrospective study of 65 patients with ureteric
stones treated by ESWL was completed.
Result: Treatment times were 68, 96 and 119 days for stones less than
5mm, 5-7mm and greater than 7mm respectively. ESWL success rates
were 92%, 94% and 68% for stones less than 5mm, 5-7mm and greater
than 7mm respectively. Passage rates following one session were 67%
for stones less than 5mm, 71% for 5-7mm and 45% for greater than
7mm; Rates related to location were 43% in the PUJ; 69% for proximal
ureter; 57% for mid, 72% for distal and 59% for VUJ. 8% of stones less
than 5mm required laser following failed ESWL, versus 32% greater than
7mm.
Conclusion: PUJ, mid-ureteric and VUJ stones have lower passage rates
than proximal and distal stones. Larger stones at these locations should be
considered for early laser treatment to avoid prolonged treatment, reduce
hospital visits and increase patient satisfaction.
0429: IS POSSUM A VALID RISK ASSESSMENT MODEL FOR PREDICTING
OUTCOMES OF MAJOR UROLOGICAL SURGERY?
Aaron Farrell, Richard Stephenson. Wirral University Teaching Hospital,
Merseyside, UK.
Introduction/Aim: NHS requirements for transparency and accountability
in surgical outcomes require accurate and fair means of measuring
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ABSTRACTSperformance. Crude mortality/morbidity rates may discriminate against
surgeons operating onmore complex cases. Risk prediction models such as
POSSUM may enable post-operative outcomes to be viewed objectively.
This audit aimed to determine whether POSSUM/P-POSSUM accurately
predicts mortality/morbidity in patients undergoing major urological
procedures.
Methods: We reviewed POSSUM/P-POSSUM scores of 110 patients un-
dergoing major urological surgery under a single surgeon. Observed and
predicted post-operative complications and mortality were compared,
measuring signiﬁcance of differences using Chi-square analysis.
Results: The mean P-POSSUM 30 day mortality risk was 4.86%, predicting
5 deaths throughout the sample. Observed mortality was 0(p ¼ 0.0177).
The mean POSSUM predicted morbidity risk was 50.96%, meaning we
would have expected to observe 56 cases inwhich complications occurred.
Observed morbidity was 43 (39%)(p ¼ 0.0127).
Conclusion: Although predictions of both mortality and morbidity were
signiﬁcantly over-estimated, the observed morbidity was proportional to
stratiﬁed P-POSSUM predictions. Whilst further studies will be required
to conﬁrm or refute these ﬁndings more generally, the POSSUM and
P-POSSUM predicted values could have value as benchmarks to allow
a fairer comparison of performance/safety between urological surgeons/
units.
0439: DOES A PATIENT SATISFACTION QUESTIONNAIRE IMPROVE QUAL-
ITY OF CARE RECEIVED IN LOCAL CONTINENCE CLINICS? AN AUDIT OF
PATIENT SATISFACTION IN A DISTRICT GENERAL HOSPITAL
Georgina Wartemberg, Eleni Anastasiadis, Sophie West,
Mohamed Hammadeh, Sharon Sutherland, Karen Briggs. Queen Elizabeth
Hospital, London, UK.
Introduction: The National Continence Audit 2010 recommends
that patient satisfaction surveys should be part of continence services.
We created a questionnaire to evaluate patient satisfaction with our
clinics.
Methods: The questionnaire was 8 closed-ended questions using a 5-
point Likert scale. The following areas were evaluated: 1) waiting time 2)
nurse 3) doctor 4) administrative staff 5) explanation of their condition 6)
investigations 7) follow-up appointment and 8) overall outcome with the
visit. The survey was conducted in 2010. Findings were presented locally
to all staff, and a sign was displayed warning that "waiting times may
be increased". After implementing changes, we repeated the survey in
2012.
Results: 53 patients participated in 2010 and 42 in 2012. The repeat
survey showed improvements in almost all areas: 98% were satisﬁed with
time waited (87% in 2010, p¼0.04); 95% were very satisﬁed with nurses
(86% in 2010, p¼0.11); 100% were very satisﬁed with doctors (71% 2010,
p<0.001), 100% were satisﬁed with explanations of investigations (95%,
p¼0.26). However, satisfaction with administration staff was reduced
(95% from 100%). Overall satisfaction was unchanged at 98% (95%CI 93-
100%).
Conclusions: There was marked improvements in how patients perceived
their treatment. This audit has led to an improved service.
0483: CT UROGRAPHY SHOULD REPLACE USS IN A ONE STOP HAEMATU-
RIA CLINIC: EVIDENCE FROM A NEPHROURETERECTOMY SERIES
Matthew Lee 1, Angus Luk 2, Derek Rosaria 1, David Yates 1. 1Dept of Urology,
Royal Hallamshire Hospital, Shefﬁeld, UK; 2University Of Shefﬁeld Medical
School, Shefﬁeld, UK.
Urothelial carcinoma of the upper urinary tract (UTUC) is rare but has to
be considered as a potential diagnosis in patients referred with haema-
turia. CT urography (CTU) is the most accurate imaging method but due to
disease rarity and radiation it is currently reserved for recurrent hae-
maturia at our institution. UTUC outcomes are poor and this may be
partly due to a diagnostic delay if CTU is used as a second line test. To
determine mode of presentation and diagnostic accuracy of initial im-
aging, we have retrospectively analysed all patients (n¼92) who under-
went nephroureterectomy at our institution between 2004-2012. Overall,
72% presented with visible haematuria (VH) and 9.5% with non-visible
haematuria (NVH), with lowest age at diagnosis of 44 and 47, respectively.
First line USS was normal in 40% of patients with VH and 44% with NVH.
All these patients had their UTUC tumour diagnosed on second line CTU.In conclusion, a large proportion of UTUC patients present without VH
(28%) and the initial USS may be normal in up to as many as 40%, thus
CTU should replace USS as the ﬁrst line imaging test for all patients >40
referred with any type of haematuria.
0538: ASIT-SURG PRIZE WINNER: CONTEMPORARY AUTOLOGOUS
FASCIAL SLING FOR FEMALE STRESS URINARY INCONTINENCE: ITS
ROLE IN THE ERA OF SYNTHETIC MID URETHRAL TAPES
Thomas Smith, Sachin Malde, James Moore. Eastbourne District General
Hospital, East Sussex, UK.
Introduction: The surgical treatment of female SUI has changed signiﬁ-
cantly over the past decade, with synthetic mid-urethral tape insertion
now standard procedure. However, this has led to an incidence of serious
mesh-related complications. The AFS has equivalent long-term success
rates but has been associated with higher post-operative morbidity and
de-novo OAB symptoms. We believe that reﬁnements in technique can
avoid these problems with none of the risks associated with mesh. Here
we review our experience with the AFS.
Methods: We retrospectively reviewed the case-notes of all patients who
underwent AFS insertion by a single surgeon over a 4-year period (2008-
2012).
Results: Thirty-eight patients were identiﬁed. 52.6% reported pure SUI
whilst 47.4% had mixed symptoms. Patients used an average of 3 pads per
day (0-8), and 26% of patients had at least one previously failed SUI pro-
cedure. 95% of patients were completely dry at latest follow-up (6 months
to 4 years). One patient developed de-novo OAB syndrome (lasting >
3months), and 2 patients (5.3%) required CISC long-term.
Conclusion: In our experience the AFS has excellent short-term cure rates
with low incidence of de-novo OAB symptoms or other complications.
Whenever mesh-related complications are unacceptable to patients the
AFS is an alternative approach.
0609: LONGEVITY OF TESTICULAR PROSTHESIS; A 10-YEAR SINGLE
INSTITUTION EXPERIENCE
Luke Teo, Ayman Younis, Peter Davey, Ben Jenkins, Pravin Menezes.
Sunderland Royal Hospital, Sunderland, UK.
Introduction: The long-term complications following insertion of silicone
testicular prostheses are poorly investigated. A retrospective study
assessed prosthesis longevity and complications at our centre.
Methods: Patients were identiﬁed by electronic records with ‘orchid-
ectomy', ‘testicular implant' and ‘testicular prosthesis' keywords as there
was no formal log of patients who received prostheses. 45 implantations in
43 patients were recorded from January 2002 to November 2012. Data
included patient demographics, orchidectomy indications, time between
orchidectomy and prosthesis insertion, and complications.
Results: 43 patients aged between 7 and 54 had primary prosthesis in-
sertions. 2 patients had a prosthesis replaced. Prosthesis insertion was
following testicular malignancy in 14 (32.6%), testicular torsion in 8 (18.6%)
and testicular aplasia in 7 patients (16.3%) respectively. Median time be-
tween orchidectomy and prosthesis insertionwas 20 months (2-240). Pain
was the most common complication in 8 (18.6%) patients. Two patients
had their prosthesis removed due to infection and pain. No spontaneous
extrusion was reported.
Conclusion: Our experience demonstrates low complication rates
following testicular prosthesis insertion. However, identiﬁcation may be
incomplete due to lack of a formal register. Following the recent compli-
cations encountered with silicone breast implants, accurate patient iden-
tiﬁcation is paramount and a formal testicular prosthesis register should
be established.
0616: A RETROSPECTIVE REVIEW OF THE MANAGEMENT OF EPIDI-
DYMO-ORCHITIS
Imeshi Wijetunga, Anthony Browning. Pinderﬁelds Hospital, MidYorkshire
Hospitals NHS Trust, Wakeﬁeld, UK.
Aims: The acute scrotum (AS) is a common presentation to on-call Urology.
We aim to determine if management of the acute scrotum at our Trust
conform to European Association of Urology guidelines and antibiotic
prescription for epididymo-orchitis meets Trust guidelines.
Methods: 208 patients presenting with AS to MYHT during the
12month period from 01.01.2011 to 31.12.2011 were identiﬁed from the
